{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T12:29:55Z","timestamp":1783686595282,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":1126,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1038\/jid.2012.227","type":"journal-article","created":{"date-parts":[[2012,7,19]],"date-time":"2012-07-19T04:21:37Z","timestamp":1342671697000},"page":"2544-2551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Predictors of Basal Cell Carcinoma in High-Risk Patients in the VATTC (VA Topical Tretinoin Chemoprevention) Trial"],"prefix":"10.1016","volume":"132","author":[{"given":"Robert K.","family":"Dyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin A.","family":"Weinstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias S.D.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amilcar E.","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen F.","family":"Bingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"VATTC Trial Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2012.227_bb0010","series-title":"Detailed Guide: Skin Cancer\u2013Nonmelanoma \u201cWhat are the Key Statistics about Nonmelanoma Skin Cancer?","author":"American Cancer Society","year":"2012"},{"key":"10.1038\/jid.2012.227_bb0015","series-title":"J Eur Acad Derm Venereol","article-title":"Oral prednisone use and risk of keratinocyte carcinoma in non-transplant population. The VATTC trial","author":"Baibergenova","year":"2011"},{"key":"10.1038\/jid.2012.227_bb0020","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/archderm.1975.01630200055004","article-title":"Multiple sequential skin cancers: the risk of skin cancer in patients with previous skin cancer","volume":"111","author":"Bergstresser","year":"1975","journal-title":"Arch Dermatol"},{"key":"10.1038\/jid.2012.227_bb0025","doi-asserted-by":"crossref","first-page":"551","DOI":"10.7861\/clinmedicine.5-6-551","article-title":"Basal cell carcinoma","volume":"5","author":"Brooke","year":"2005","journal-title":"Clin Med"},{"key":"10.1038\/jid.2012.227_bb0030","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1002\/cncr.24284","article-title":"Actinic keratoses: natural history and risk of malignant transformation in the VATTC Trial","volume":"115","author":"Criscione","year":"2009","journal-title":"Cancer"},{"key":"10.1038\/jid.2012.227_bb0035","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/jnci\/djn262","article-title":"Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention: VATTC Trial","volume":"100","author":"Christian","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/jid.2012.227_bb0040","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1001\/archderm.137.9.1162","article-title":"Risk factors for basal cell carcinoma in a mediterranean population: role of recreational sun exposure early in life","volume":"137","author":"Corona","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1038\/jid.2012.227_bb0045","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1177\/120347540200600503","article-title":"A 10-year prospective study of patients with skin cancer","volume":"6","author":"Czarnecki","year":"2002","journal-title":"J Cutan Med Surg"},{"key":"10.1038\/jid.2012.227_bb0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7326\/0003-4819-150-1-200901060-00004","article-title":"Association between statin use and risk of keratinocyte carcinomas in the Veterans Affairs Topical Tretinoin Chemoprevention Trial","volume":"150","author":"Dore","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1038\/jid.2012.227_bb0055","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1001\/archderm.1973.01620270024004","article-title":"Value of follow-up after treatment of basal cell carcinoma","volume":"108","author":"Epstein","year":"1973","journal-title":"Arch Dermatol"},{"key":"10.1038\/jid.2012.227_bb0060","first-page":"365","article-title":"Changes in skin cancer morbidity between 1971\u201372 and 1977\u201378","volume":"69","author":"Fears","year":"1982","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/jid.2012.227_bb0065","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1001\/archderm.1995.01690140041006","article-title":"Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer, I: basal cell carcinoma","volume":"131","author":"Gallagher","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1038\/jid.2012.227_bb0070","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0190-9622(90)70234-9","article-title":"Trends in basal cell carcinoma, squamous cell carcinoma, and melanoma of the skin from 1973 through 1987","volume":"23","author":"Gallagher","year":"1990","journal-title":"J Am Acad Dermotol"},{"key":"10.1038\/jid.2012.227_bb0075","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1365-2133.2009.09341.x","article-title":"Tolerability of high-dose topical tretinoin: the VA Topical Tretinoin Chemoprevention (VATTC) Trial","volume":"161","author":"Geng","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2012.227_bb0080","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1001\/jama.1989.03430150065027","article-title":"The emerging epidemic of melanoma and squamous cell skin cancer","volume":"262","author":"Glass","year":"1989","journal-title":"JAMA"},{"key":"10.1038\/jid.2012.227_bb0085","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/archderm.141.9.1123","article-title":"Incidence of cancer among patients with atopic dermatitis","volume":"141","author":"Hagstromer","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1038\/jid.2012.227_bb0090","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archderm.135.7.781","article-title":"Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995","volume":"135","author":"Hannuksela-Svahn","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1038\/jid.2012.227_bb0095","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-4362.1989.tb02534.x","article-title":"Risk factors for basal cell carcinoma","volume":"28","author":"Hogan","year":"1989","journal-title":"Int J Dermatol"},{"key":"10.1038\/jid.2012.227_bb0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/1047-2797(90)90015-K","article-title":"Risk factors for basal cell carcinoma in prospective cohort of women","volume":"1","author":"Hunter","year":"1990","journal-title":"Ann Epidemiol"},{"key":"10.1038\/jid.2012.227_bb0105","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jaad.2007.03.021","article-title":"Reliability of the histopathologic diagnosis of keratinocyte carcinomas","volume":"57","author":"Jagdeo","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2012.227_bb0110","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1001\/jama.1992.03480240067036","article-title":"Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. The Skin Cancer prevention Study Group","volume":"267","author":"Karagas","year":"1992","journal-title":"JAMA"},{"key":"10.1038\/jid.2012.227_bb0115","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2133.1994.tb02920.x","article-title":"The emerging epidemic of skin cancer","volume":"130","author":"Ko","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2012.227_bb0120","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ijc.2910480504","article-title":"Pigmentary and cutaneous risk factors for non-melanocytic skin cancer: a case-control study","volume":"48","author":"Kricker","year":"1991","journal-title":"Int J Cancer"},{"key":"10.1038\/jid.2012.227_bb0125","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jaad.2010.02.014","article-title":"Prospective quality of life impact of keratinocyte carcinomas: observations from the VATTC Trial","volume":"63","author":"Lee","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2012.227_bb0130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2340\/00015555-0972","article-title":"Prospective quality of life impact of actinic keratoses: observations from the Veterans Affairs Topical Tretinoin Chemoprevention Trial","volume":"91","author":"Lee","year":"2011","journal-title":"Acta Dermatol Venereol"},{"key":"10.1038\/jid.2012.227_bb0135","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archderm.136.12.1524","article-title":"Risk of developing a subsequent nonmelonoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis","volume":"136","author":"Marcil","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1038\/jid.2012.227_bb0140","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0190-9622(93)70003-C","article-title":"Risk of another basal cell carcinoma developing after treatment of a basal cell carcinoma","volume":"28","author":"Marghoob","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2012.227_bb0145","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000100879","article-title":"Lack of association between exposure to topical calcineurin inhibitors and skin cancer in adults","volume":"214","author":"Margolis","year":"2007","journal-title":"Dermatology"},{"key":"10.1038\/jid.2012.227_bb0150","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1365-2133.2003.05352.x","article-title":"Lifestyle differences in twin pairs discordant for basal cell carcinoma of the skin","volume":"149","author":"Milan","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2012.227_bb0155","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0190-9622(08)81509-5","article-title":"Nonmelanoma skin cancer in the United States: incidence","volume":"30","author":"Miller","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2012.227_bb0160","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jaad.2003.09.024","article-title":"The lack of a relationship between atopic dermatitis and nonmelanoma skin cancers","volume":"50","author":"Ming","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2012.227_bb0165","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/pds.2142","article-title":"Association between non-steroidal anti-inflammatory drugs and keratinocyte carcinomas of the skin among participants in the Veterans Affairs Topical Tretinoin Chemoprevention Trial","volume":"20","author":"Nunes","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1038\/jid.2012.227_bb0170","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.0022-202X.2005.23839.x","article-title":"The risk of cancer among patients previously hospitalized for atopic dermatitis","volume":"125","author":"Olsen","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2012.227_bb0175","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archderm.142.5.633","article-title":"Topical calcineurin inhibitors for atopic dermatitis: balancing clinical benefit and possible risks","volume":"142","author":"Qureshi","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1038\/jid.2012.227_bb0180","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1468-3083.2004.00956.x","article-title":"Risk of subsequent non-melanoma skin cancer in a cohort of patients with primary basal cell carcinoma","volume":"18","author":"Revenga","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1038\/jid.2012.227_bb0185","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/1097-0142(19870701)60:1<118::AID-CNCR2820600122>3.0.CO;2-1","article-title":"Risk of developing another basal cell carcinoma: a 5-year prospective study","volume":"60","author":"Robinson","year":"1987","journal-title":"Cancer"},{"key":"10.1038\/jid.2012.227_bb0190","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/archdermatol.2010.19","article-title":"Incidence estimate of non-melanoma skin cancer in the United States, 2006","volume":"146","author":"Rogers","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1038\/jid.2012.227_bb0195","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1056\/NEJMra044151","article-title":"Basal cell carcinoma: current concepts","volume":"353","author":"Rubin","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1038\/jid.2012.227_bb0200","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/0190-9622(90)70343-G","article-title":"The risk of developing subsequent nonmelanoma skin cancers","volume":"23","author":"Schreiber","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2012.227_bb0205","series-title":"Indidence of Nonmelanoma Skin Cancer in the United States (NIH Publication No. 83-2433)","author":"Scotto","year":"1983"},{"key":"10.1038\/jid.2012.227_bb0210","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/archderm.142.9.1233","article-title":"Topical calcineurin inhibitors labeling: putting the \u201cBox\u201d in perspective","volume":"142","author":"Stern","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1038\/jid.2012.227_bb0215","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1365-2133.2005.06911.x","article-title":"Prognostic factors for subsequent basal cell carcinoma: implications for follow-up","volume":"153","author":"van Iersal","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2012.227_bb0220","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1001\/archderm.1980.01640280090030","article-title":"The relative importance of risk factors in nonmelanoma carcinoma","volume":"116","author":"Vitaliano","year":"1980","journal-title":"Arch Dermatol"},{"key":"10.1038\/jid.2012.227_bb0225","first-page":"1055","article-title":"Reliability of counting actinic keratoses before and after brief consensus discussion: the V A Topical Tretinoin Chemoprevention (VATTC) Trial","volume":"137","author":"Weinstock","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1038\/jid.2012.227_bb0230","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/jid.2011.483","article-title":"Tretinoin and the prevention of keratinocyte carcinoma (basal and squamous cell carcinoma of the skin): A Veterans Affairs Randomized Chemoprevention Trial","volume":"132","author":"Weinstock","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2012.227_bb0235","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1001\/archdermatol.2008.542","article-title":"Topical tretinoin therapy and all-cause mortality","volume":"145","author":"Weinstock","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1038\/jid.2012.227_bb0240","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jaad.2009.02.022","article-title":"Quality of life in the actinic neoplasia syndrome: the VA Topical Tretinoin Chemoprevention (VATTC) Trial","volume":"61","author":"Weinstock","year":"2009","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15355093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15355093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T13:42:17Z","timestamp":1743946937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15355093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0022202X15355093"],"URL":"https:\/\/doi.org\/10.1038\/jid.2012.227","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717953636.793459244","asserted-by":"object"}]},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of Basal Cell Carcinoma in High-Risk Patients in the VATTC (VA Topical Tretinoin Chemoprevention) Trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2012.227","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}